PAR-2 has been implicated in invasion and metastasis in cancers of the breast [15,17], colon [7,21], gastrium [19,20], pancreas [22,23], lungs [14], prostate [16], and melanoma [16], and glioblastoma [25]. This evidence concerns the gene F2RL1 and glioblastoma.